Endothelial Damage-dominant Nephritis Related to IgA Vasculitis after 11 Years’ Use of Infliximab for Rheumatoid Arthritis

6Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

A 43-year-old Japanese woman with rheumatoid arthritis treated by infliximab and methotrexate for 11 years was admitted for proteinuria and purpura. A kidney biopsy revealed endothelial damage-dominant nephritis with IgA deposition. Infliximab and methotrexate were discontinued, and tocilizumab was started; however, proteinuria persisted. Therefore, tocilizumab was discontinued, and oral prednisolone and methylprednisolone pulse therapy were administered. After 6 months, urinary protein was less than 0.1 g/day, and purpura subsided. To our knowledge, this is the first case of endothelial damage-dominant nephritis related to IgA vasculitis involving the skin and kidney after long-term use of infliximab and methotrexate.

Cite

CITATION STYLE

APA

Fukuda, M., Sawa, N., Ikuma, D., Oba, Y., Mizuno, H., Yamanouchi, M., … Ubara, Y. (2023). Endothelial Damage-dominant Nephritis Related to IgA Vasculitis after 11 Years’ Use of Infliximab for Rheumatoid Arthritis. Internal Medicine, 62(1), 81–85. https://doi.org/10.2169/internalmedicine.9059-21

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free